Animal Health: Foot-and-Mouth Disease

Encyclopedia of Agriculture and Food Systems

Volumn , Issue , 2014, Pages 327-345

  Diaz San Segundo, F ^a   Medina, G N ^a   Grubman, M J ^a   de los Santos, T ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Adaptive immunity; Antigenic variation; Antiviral; Biotherapeutic; Carrier state; Foot and mouth disease; IFN; Inactivated virus vaccines; Innate immunity; Interferon; Live attenuated vaccines; Outbreaks; Pathogenesis; Persistence; Vaccines; Virulence

Indexed keywords

EID: 84962298831     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-52512-3.00195-9     Document Type: Chapter

References (258)

1. Acharya R., Fry E., Stuart D., et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9A resolution. Nature 1989, 337(6209):709-716.
2. Ahl R., Rump A. Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infection and Immunity 1976, 14(3):603-606.
3. Alexandersen S., Brotherhood I., Donaldson A.I. Natural aerosol transmission of foot-and-mouth disease virus to pigs: Minimal infectious dose for strain O1 Lausanne. Epidemiology and Infection 2002, 128(2):301-312.
4. Alexandersen S., Donaldson A.I. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiology and Infection 2002, 128(2):313-323.
5. Alexandersen S., Zhang Z., Donaldson A.I. Aspects of the persistence of foot-and-mouth disease virus in animals - the carrier problem. Microbes and Infection 2002, 4(10):1099-1110.
6. Alexandersen S., Zhang Z., Donaldson A.I., Garland A.J.M. The pathogenesis and diagnosis of foot-and-mouth disease. Journal of Comparative Pathology 2003, 129:1-36.
7. Alexandersen S., Zhang Z., Reid S.M., Hutchings G.H., Donaldson A.I. Quantities of infectious virus and viral RNA recovered from sheep and cattle experimentally infected with foot-and-mouth disease virus O UK 2001. Journal of General Virology 2002, 83(Pt 8):1915-1923.
8. Almeida M., Rieder E., Chinsangaram J., et al. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: Difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Research 1998, 55(1):49-60.
9. Ambros V., Baltimore D. Purification and properties of a HeLa cell enzyme able to remove the 5'-terminal protein from poliovirus RNA. Journal of Biological Chemistry 1980, 255(14):6739-6744.
10. Ambros V., Pettersson R.F., Baltimore D. An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5' terminal protein. Cell 1978, 15(4):1439-1446.
11. Andreev D.E., Fernandez-Miragall O., Ramajo J., et al. Differential factor requirement to assemble translation initiation complexes at the alternative start codons of foot-and-mouth disease virus RNA. RNA 2007, 13(8):1366-1374.
12. Ank W., West H., Paludan S.R. IFN-lambda: Novel antiviral cytokines. Journal of Interferon & Cytokine Research 2006, 26:373-379.
13. Arias A., Perales C., Escarmis C., Domingo E. Deletion mutants of VPg reveal new cytopathology determinants in a picornavirus. PLoS One 2010, 5:e10735.
14. Arzt J., Baxt B., Grubman M.J., et al. The pathogenesis of foot-and-mouth disease II: Viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transboundary and Emerging Diseases 2011, 58(4):305-326.
15. Arzt J., Juleff N., Zhang Z., Rodriguez L.L. The pathogenesis of foot-and-mouth disease I: Viral pathways in cattle. Transboundary and Emerging Diseases 2011, 58(4):291-304.
16. Arzt J., Pacheco J.M., Rodriguez L.L. The early pathogenesis of foot-and-mouth disease in catte after aerosol inoculation. Identification of the nasopharynx as the primary site of infection. Veterinary Pathology 2010, 47:1048-1063.
17. Bablanian G.M., Grubman M.J. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli. Virology 1993, 197(1):320-327.
18. Bachrach H.L. Foot-and-mouth disease. Annual Review of Microbiology 1968, 22:201-244.
19. Bachrach H.L., Moore D.M., McKercher P.D., Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 1975, 115(6):1636-1641.
20. Baranowski E., Sevilla N., Verdaguer N., et al. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. Journal of Virology 1998, 72(8):6362-6372.
21. Barteling S.J., Cassimi N.I. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by combination of binary ethyleneimine and formaldehyde. Developmental Biology (Basel) 2004, 119:449-455.
22. Barton D.J., O'Donnell B.J., Flanegan J.B. 5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO Journal 2001, 20(6):1439-1448.
23. Basler C.F., Garcia-Sastre A. Viruses and the type I interferon antiviral system: Induction and evasion. International Reviews of Immunology 2002, 21:305-337.
24. Bautista E.M., Ferman G.S., Golde W.T. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Veterinary Immunology and Immunopathology 2003, 92(1-2):61-73.
25. Bautista E.M., Ferman G.S., Gregg D., et al. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. Journal of Virology 2005, 79:4838-4847.
26. Baxt B., Mason P.W. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 1995, 207(2):503-509.
27. Beard C.W., Mason P.W. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. Journal of Virology 2000, 74(2):987-991.
28. Belsham G.J. Influence of the Leader protein coding region of foot-and-mouth disease virus on virus replication. Journal of General Virology 2013, 94(Pt 7):1486-1495.
29. Belsham G.J., Brangwyn J.K. A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: Involvement with the role of L protease in translational control. Journal of Virology 1990, 64(11):5389-5395.
30. Belsham G.J., McInerney G.M., Ross-Smith N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. Journal of Virology 2000, 74(1):272-280.
31. Berger H.G., Straub O.C., Ahl R., Tesar M., Marquardt O. Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to non-structural virus proteins. Vaccine 1990, 8(3):213-216.
32. Bergmann I.E., de Mello P.A., Neitzert E., Beck E., Gomes I. Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens. American Journal of Veterinary Research 1993, 54(6):825-831.
33. Bergmann I.E., Malirat V., Auge de Mello P., Gomes I. Detection of foot-and-mouth disease viral sequences in various fluids and tissues during persistence of the virus in cattle. American Journal of Veterinary Research 1996, 57(2):134-137.
34. Bergmann I.E., Malirat V., Neitzert E., et al. Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: A combined system of an indirect ELISA 3ABC with an enzyme-linked immunoelectrotransfer blot assay. Archives of Virology 2000, 145:473-489.
35. Berryman S., Brooks E., Burman A., et al. Foot-and-mouth disease virus induces autophagosomes during cell entry via a class III phosphatidylinositol 3-kinase-independent pathway. Journal of Virology 2012, 86(23):12940-12953.
36. Berryman S., Clark S., Monaghan P., Jackson T. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. Journal of Virology 2005, 79(13):8519-8534.
37. Birtley J.R., Knox S.R., Jaulent A.M., et al. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. Journal of Biological Chemistry 2005, 280(12):11520-11527.
38. Bolwell C., Brown A.L., Barnett P.V., et al. Host cell selection of antigenic variants of foot-and-mouth disease virus. Journal of General Virology 1989, 70(Pt 1):45-57.
39. Borca M.V., Fernandez F.M., Sadir A.M., Braun M., Schudel A.A. Immune response to foot-and-mouth disease virus in a murine experimental model: Effective thymus-independent primary and secondary reaction. Immunology 1986, 59(2):261-267.
40. Borrego B., Novella I.S., Giralt E., Andreu D., Domingo E. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. Journal of Virology 1993, 67(10):6071-6079.
41. Brooksby J.B. Portraits of viruses: Foot-and-mouth disease virus. Intervirology 1982, 18(1-2):1-23.
42. Brooks D.G., Trifilo M.J., Edelmann K.H., et al. Interleukin-10 determines viral clearance or persistence in vivo. Nature Medicine 2006, 12(11):1301-1309.
43. Brown C.C., Meyer R.F., Olander H.J., House C., Mebus C.A. A pathogenesis study of foot-and-mouth disease in cattle, using in situ hybridization. Canadian Journal of Veterinary Research 1992, 56(3):189-193.
44. Brown C.C., Piccone M.E., Mason P.W., McKenna T.S., Grubman M.J. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. Journal of Virology 1996, 70(8):5638-5641.
45. Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 1992, 10(14):1022-1026.
46. Brown J.K., McAleese S.M., Thornton E.M., et al. Integrin-alphavbeta6, a putative receptor for foot-and-mouth disease virus, is constitutively expressed in ruminant airways. Journal of Histochemistry and Cytochemistry 2006, 54(7):807-816.
47. Burrows R. Excretion of foot-and-mouth disease prior to the development of lesions. Veterinary Record 1968, 82:387-388.
48. Caliguiri L.A., Tamm I. Action of guanidine on the replication of poliovirus RNA. Virology 1968, 35(3):408-417.
49. Callahan J.D., Brown F., Osorio F.A., et al. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. Journal of the American Veterinary Medical Association 2002, 220(11):1636-1642.
50. Cheneau Y., Rweyemamu M.M., Astudillo V., Lubroth J. Global initiatives for the progressive control and eradication of foot-and-mouth disease. Foot and Mouth Disease: Control Strategies 2003, 247-257. Elsevier, Paris. B. Vicari (Ed.).
51. Chen W., Yan W., Du Q., et al. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. Journal of Virology 2004, 78(13):6900-6907.
52. Childerstone A.J., Cedillo-Baron L., Foster-Cuevas M., Parkhouse R.M. Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. Journal of General Virology 1999, 80(Pt 3):663-669.
53. Chinsangaram J., Koster M., Grubman M.J. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. Journal of Virology 2001, 12:5498-5503.
54. Chinsangaram J., Mason P.W., Grubman M.J. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998, 16(16):1516-1522.
55. Chinsangaram J., Moraes M.P., Koster M., Grubman M.J. Novel viral disease control strategy: Adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. Journal of Virology 2003, 77:1621-1625.
56. Chinsangaram J., Piccone M.E., Grubman M.J. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. Journal of Virology 1999, 73(12):9891-9898.
57. Clarke B.E., Sangar D.V. Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA. Journal of General Virology 1988, 69(Pt 9):2313-2325.
58. Collen T., Pullen L., Doel T.R. T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. Journal of General Virology 1989, 70(Pt 2):395-403.
59. Cornell C.T., Kiosses W.B., Harkins S., Whitton J.L. Inhibition of protein trafficking by coxsackievirus B3: Multiple viral proteins target a single organelle. Journal of Virology 2006, 80:6637-6647.
60. Cottam E.M., Wadsworth J., Shaw A.E., et al. Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathogens 2008, 4(4):e1000050.
61. Curry S., Abrams C.C., Fry E., et al. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. Journal of Virology 1995, 69(1):430-438.
62. Curry S., Fry E., Blakemore W., et al. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 1996, 4(2):135-145.
63. Curry S., Fry E., Blakemore W., et al. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: The structure of empty capsids of foot-and-mouth disease virus. Journal of Virology 1997, 71(12):9743-9752.
64. Dawe P.S., Flanagan F.O., Madekurozwa R.L., et al. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Veterinary Record 1994, 134(10):230-232.
65. Dawe P.S., Sorensen K., Ferris N.P., et al. Experimental transmission of foot-and-mouth disease virus from carrier African buffalo (Syncerus caffer) to cattle in Zimbabwe. Veterinary Record 1994, 134(9):211-215.
66. Devaney M.A., Vakharia V.N., Lloyd R.E., Ehrenfeld E., Grubman M.J. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. Journal of Virology 1988, 62(11):4407-4409.
67. Dias C.C., Moraes M.P., Diaz-San Segundo F., de los Santos T., Grubman M.J. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. Journal of Interferon and Cytokine Research 2011, 31:227-236.
68. Dias C.C., Moraes M.P., Weiss M., et al. Novel antiviral therapeutics to control foot-and-mouth disease. Journal of Interferon and Cytokine Research 2012, 32:462-473.
69. Diaz-San Segundo F., Dias C.C., Moraes M.P., et al. Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease. Journal of Virology 2013, 87:5447-5460.
70. Diaz-San Segundo, F., Montiel, N., de los Santos, T., Grubman, M., 2013b. Understanding the Mechanisms of Interferon-Induced Protection against Foot-and-Mouth Disease. Hong Kong: iConcept Press.
71. Diaz-San Segundo F., Moraes M.P., de los Santos T., Dias C.C., Grubman M.J. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. Journal of Virology 2010, 84:2063-2077.
72. Diaz-San Segundo F., Rodriguez-Calvo T., de Avila A., Sevilla N. Immunosuppresion during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One 2009, 4:e5659.
73. Diaz-San Segundo F., Salguero F.J., de Avila A., et al. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. Journal of Virology 2006, 80:2369-2379.
74. Diaz-San Segundo F., Weiss M., Perez-Martin E., et al. Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease. Journal of Virology 2012, 86:1316-1327.
75. Díaz-San Segundo F., Weiss M., Perez-Martín E., et al. Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Virology 2011, 413:283-292.
76. Doedens J.R., Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO Journal 1995, 14(5):894-907.
77. Doel T.R. FMD vaccines. Virus Research 2003, 91(1):81-99.
78. Doel T.R., Pullen L. International bank for foot-and-mouth disease vaccine: Stability studies with virus concentrates and vaccines prepared from them. Vaccine 1990, 8:473-478.
79. Domingo E., Baranowski E., Escarmis C., Sobrino F. Foot-and-mouth disease virus. Comparative Immunology, Microbiology and Infectious Diseases 2002, 25(5-6):297-308.
80. Domingo E., Davila M., Ortin J. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 1980, 11(3-4):333-346.
81. Domingo E., Diez J., Martinez M.A., et al. New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. Journal of General Virology 1993, 74(Pt 10):2039-2045.
82. Donaldson A.I. Foot-and-mouth disease: The principal features. Irish Veterinary Journal 1987, 41:325-327.
83. Dunn C.S., Donaldson A.I. Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Veterinary Record 1997, 141(7):174-175.
84. Eigen M. Self organization of matter and the evolution of biological macromolecules. Naturwissenschaften 1971, 58(10):465-523.
85. Ellard F.M., Drew J., Blakemore W.E., Stuart D.I., King A.M. Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. Journal of General Virology 1999, 80(Pt 8):1911-1918.
86. Fajardo T.J., Rosas M.F., Sobrino F., Martinez-Salas E. Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity. PLoS One 2012, 7:e41382.
87. Falk M.M., Grigera P.R., Bergmann I.E., et al. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. Journal of Virology 1990, 64(2):748-756.
88. Falk M.M., Sobrino F., Beck E. VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. Journal of Virology 1992, 66(4):2251-2260.
89. Fensterl V., Sen G.C. Interferons and viral infections. Biofactors 2009, 35:14-20.
90. Ferrer-Orta C., Agudo R., Domingo E., Verdaguer E. Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Current Opinion in Structural Biology 2009, 19:752-758.
91. Ferrer-Orta C., Arias A., Agudo R., et al. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO Journal 2006, 25:880-888.
92. Forss S., Strebel K., Beck E., Schaller H. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Research 1984, 12(16):6587-6601.
93. Fowler V.L., Barnett P.V. Progress in the development of DNA vaccines against foot-and-mouth disease. Expert Review of Vaccines 2012, 11:481-493.
94. Fowler V.L., Bashiruddin J.B., Maree F.F., et al. Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 2011, 29(46):8405-8411.
95. Fracastorius, H., 1546. De sympathia et antipathia rerum liber unus. De contagione et contagiosis morbis et eorum curatione liber I, Venice, Heirs of L.A. Junta.
96. Frese M., Schwarzle V., Barth K., et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002, 35:694-703.
97. Fry E.E., Lea S.M., Jackson T., et al. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO Journal 1999, 18(3):543-554.
98. Giraudo A.T., Beck E., Strebel K., et al. Identification of a nucleotide deletion in parts of polypeptide 3A intwo independent attenuated aphthovirus strains. Virology 1990, 177:780-783.
99. Gladue D.P., O'Donnell V., Baker-Branstetter R., et al. Foot-and-mouth disease virus modulates cellular vimentin for virus survival. Journal of Virology 2013, 87(12):6794-6803.
100. Gladue D.P., O'Donnell V., Baker-Branstetter R., et al. Foot-and-mouth disease virus nonstructural protein 2C interacts with Beclin1, modulating virus replication. Journal of Virology 2012, 86(22):12080-12090.
101. Golde W.T., Pacheco J.M., Duque H., et al. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine 2005, 23:5775-5782.
102. Grubman M.J. New approaches to rapidly control foot-and-mouth disease outbreaks. Expert Review of Anti-infective Therapy 2003, 1(4):579-586.
103. Grubman M.J., Baxt B. Foot-and-mouth disease. Clinical Microbiology Reviews 2004, 17(2):465-493.
104. Grubman M.J., de los Santos T. Foot-and-mouth disease virus L peptidase. Handbook of Proteolytic Enzymes 2012, Elsevier Ltd, Waltham, MA. third ed. G.S.N.D. Rawlings (Ed.).
105. Grubman M.J., Diaz-San Segundo F., Dias C.C.A., et al. Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease. Future Virology 2012, 7:767-778.
106. Grubman M.J., Moraes M., Schutta C., et al. Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: The first decade. Future Virology 2010, 5:51-64.
107. Grubman M.J., Morgan D.O., Kendall J., Baxt B. Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. Journal of Virology 1985, 56(1):120-126.
108. Grubman M.J., Zellner M., Bablanian G., Mason P.W., Piccone M.E. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 1995, 213(2):581-589.
109. Guarne A., Tormo J., Kirchweger R., et al. Structure of the foot-and-mouth disease virus leader protease: A papain-like fold adapted for self-processing and eIF4G recognition. EMBO Journal 1998, 17(24):7469-7479.
110. Gulevich A.Y., Yusupova R.A., Drygin Y.F. VPg unlinkase, the phosphodiesterase that hydrolyzes the bond between VPg and picornavirus RNA: A minimal nucleic moiety of the substrate. Biochemistry (Mosc) 2002, 67(6):615-621.
111. Guzylack-Piriou L., Bergamin F., Gerber M., McCullough K.C., Summerfield A. Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. European Journal of Immunology 2006, 36(7):1674-1683.
112. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annual Review of Genetics 2009, 43:67-93.
113. Herold J., Andino R. Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Molecular Cell 2001, 7(3):581-591.
114. Hyde J.L., Blackwell J.H., Callis J.J. Effect of pasteurization and evaporation on foot-and-mouth disease virus in whole milk from infected cows. Canadian Journal of Comparative Medicine 1975, 39:305-309.
115. Jackson A.L., O'Neill H., Maree F., et al. Mosaic structure of foot-and-mouth disease virus genomes. Journal of General Virology 2007, 88(Pt 2):487-492.
116. Jackson T., Ellard F.M., Ghazaleh R.A., et al. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. Journal of Virology 1996, 70(8):5282-5287.
117. Joo Y.-S., Ann S.-H., Kim O.-K., Lubroth J., Sur J.-H. Foot-and-mouth disease eradication efforts in the Republic of Korea. Canadian Journal of Veterinary Research 2002, 66:122-124.
118. Joshi G., Sharma R., Kakker N.K. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes. Vaccine 2009, 27(48):6656-6661.
119. Juleff N., Windsor M., Lefevre E.A., et al. Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naive cattle. Journal of Virology 2009, 83:3626-3636.
120. Juleff N., Windsor M., Reid E., et al. Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One 2008, 3(10):e3434.
121. King A.M., McCahon D., Saunders K., Newman J.W., Slade W.R. Multiple sites of recombination within the RNA genome of foot-and-mouth disease virus. Virus Research 1985, 3(4):373-384.
122. Kirchweger R., Ziegler E., Lamphear B.J., et al. Foot-and-mouth disease virus leader proteinase: Purification of the Lb form and determination of its cleavage site on eIF-4 gamma. Journal of Virology 1994, 68(9):5677-5684.
123. Kitching P. Foot-and-mouth disease. Bovine Medicine: Diseases and Husbandry of Cattle 1992, 537-543. Blackwell Science Inc., Oxford. A.H. Andrews, R.W. Blowey, H. Boyd, R.G. Eddy (Eds.).
124. Kitching P., Alexandersen S. Clinical variation in foot-and-mouth disease: Pigs. Revue Scientifique et Technique (International Office of Epizootics) 2002, 21:513-518.
125. Kleid D.G., Yansura D., Small B., et al. Cloned viral protein vaccine for foot-and-mouth disease: Responses in cattle and swine. Science 1981, 214(4525):1125-1129.
126. Kleina L.G., Grubman M.J. Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. Journal of Virology 1992, 66(12):7168-7175.
127. Knipe T., Rieder E., Baxt B., Ward G., Mason P.W. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. Journal of Virology 1997, 71(4):2851-2856.
128. Kozak M. How do eucaryotic ribosomes select initiation regions in messenger RNA?. Cell 1978, 15:1109-1123.
129. Kuhn R., Luz N., Beck E. Functional analysis of the internal translation initiation site of foot- and-mouth disease virus. Journal of Virology 1990, 64(10):4625-4631.
130. Lannes N., Python S., Summerfield A. Interplay of foot-and-mouth disease virus, antibodies and plasmacytoid dendritic cells: Virus opsonization under non-neutralizing conditions results in enhanced interferon-alpha responses. Veterinary Research 2012, 43:64.
131. Lawrence P., Rieder E. Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus. Journal of Virology 2009, 83(21):11356-11366.
132. Lawrence P., Schafer E.A., Rieder E. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology 2012, 425(1):40-52.
133. Lea S., Abu-Ghazaleh R., Blakemore W., et al. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure 1995, 3(6):571-580.
134. Lea S., Hernandez J., Blakemore W., et al. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 1994, 2(2):123-139.
135. Li Z., Yi Y., Yin X., Zhang Z., Liu J. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS One 2008, 3:e2273.
136. Loeffler F., Frosch P. Summarischer Bericht uber die Ergebnisse der Untersuchungen zur Erforschung der Maul- und Klauenseuche. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene 1897, 22:257-259.
137. Lopez de Quinto S., Martinez-Salas E. Involvement of the aphthovirus RNA region located between the two functional AUGs in start codon selection. Virology 1999, 255:324-336.
138. Lubroth J., Grubman M.J., Burrage T.G., Newman J.F., Brown F. Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals. Vaccine 1996, 14(5):419-427.
139. Luz N., Beck E. A cellular 57kDa protein binds to two regions of the internal translation initiation site of foot-and-mouth disease virus. FEBS Letters 1990, 269(2):311-314.
140. Mahy B.W. Overview of foot-and-mouth disease and its impact as a re-emergent viral infection. Foot-and-Mouth Disease: Current Perspectives 2004, 437-446. Horizon Bioscience, Cambridge, (Chapter 17). F. Domingo (Ed.).
141. Martín-Acebes M., González-Magaldi M., Sandvig K., Sobrino F., Armas-Portela R. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. Virology 2007, 369:105-118.
142. Martinez M.A., Dopazo J., Hernandez J., et al. Evolution of the capsid protein genes of foot-and-mouth disease virus: Antigenic variation without accumulation of amino acid substitutions over six decades. Journal of Virology 1992, 66(6):3557-3565.
143. Martinez M.A., Verdaguer N., Mateu M.G., Domingo E. Evolution subverting essentiality: Dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proceedings of the National Academy of Sciences USA 1997, 94(13):6798-6802.
144. Martinez-Salas E., Ramos R., Lafuente E., Lopez de Quinto S. Functional interactions in internal translation initiation directed by viral and cellular IRES elements. Journal of General Virology 2001, 82(Pt 5):973-984.
145. Mason P.W., Baxt B., Brown F., et al. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 1993, 192(2):568-577.
146. Mason P.W., Bezborodova S.V., Henry T.M. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. Journal of Virology 2002, 76(19):9686-9694.
147. Mason P.W., Grubman M.J. Foot-and-mouth disease. Vaccines for Biodefense and Emerging and Neglected Diseases 2009, 359-376. Elsevier Press, Waltham, MA. A. Stanberry (Ed.).
148. Mason P.W., Grubman M.J., Baxt B. Molecular basis of pathogenesis of FMDV. Virus Research 2003, 91(1):9-32.
149. Mason P.W., Piccone M.E., McKenna T.S., Chinsangaram J., Grubman M.J. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997, 227(1):96-102.
150. Mason P.W., Rieder E., Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proceedings of the National Academy of Sciences USA 1994, 91(5):1932-1936.
151. McCullough K.C., Parkinson D., Crowther J.R. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 1988, 65(2):187-191.
152. McKenna T.S., Lubroth J., Rieder E., Baxt B., Mason P.W. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. Journal of Virology 1995, 69(9):5787-5790.
153. Medina M., Domingo E., Brangwyn J.K., Belsham G.J. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 1993, 194(1):355-359.
154. Merad M., Manz M.G. Dendritic cells homeostasis. Blood 2009, 113:3418-3427.
155. Mezencio J.M., Babcock G.D., Kramer E., Brown F. Evidence for the persistence of foot-and-mouth disease virus in pigs. Veterinary Journal 1999, 157(3):213-217.
156. Moffat K., Howell G., Knox C., et al. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. Journal of Virology 2005, 79(7):4382-4395.
157. Moffat K., Knox C., Howell G., et al. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. Journal of Virology 2007, 81(3):1129-1139.
158. Mohamed F., Swafford S., Petrowski H., et al. Foot-and-mouth disease in feral swine: Susceptibility and transmission. Transboundary and Emerging Diseases 2011, 58(4):358-371.
159. Monaghan P., Gold S., Simpson J., et al. The alpha(v)beta6 integrin receptor for foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. Journal of General Virology 2005, 86:2769-2780.
160. Moonen P., Schrijver R. Carriers of foot-and-mouth disease virus: A review. Veterinary Q 2000, 22(4):193-197.
161. Moraes M.P., Chinsangaram J., Brum M.C., Grubman M.J. Immediate protection of swine from foot-and-mouth disease: A combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003, 22(2):268-279.
162. Moraes M.P., Diaz-San Segundo F.D., Dias C.C., Pena L., Grubman M.J. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine 2011, 29:9431-9440.
163. Moraes M.P., de Los Santos T., Koster M., et al. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. Journal of Virology 2007, 81(13):7124-7135.
164. Moraes M.P., Mayr G.A., Grubman M.J. pAd5-Blue: Direct ligation system for engineering recombinant adenovirus constructs. BioTechniques 2001, 31:1054-1056.
165. Moraes M.P., Mayr G.A., Mason P.W., Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002, 20(11-12):1631-1639.
166. Nayak A., Goodfellow I.G., Belsham G.J. Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. Journal of Virology 2005, 79:7698-7706.
167. Neff S., Sa-Carvalho D., Rieder E., et al. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. Journal of Virology 1998, 72(5):3587-3594.
168. Netherton C., Moffat K., Brooks E., Wileman T. A guide to viral inclusions, membrane rearrangenments, factories, and viroplasm produced during virus replication. Advances in Virus Research 2007, 70:101-182.
169. Nfon C.K., Ferman G.S., Toka F.N., Gregg D.A., Golde W.T. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunology 2008, 21:68-77.
170. Nfon C.K., Toka F.N., Kenney M., Pacheco J.M., Golde W.T. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunology 2010, 23:29-41.
171. Ng K.K., Arnold J.J., Cameron C.E. Structure-function relationships among RNA-dependent RNA polymerases. Current Topics in Microbiology and Immunology 2008, 320:137-156.
172. Nishiura H., Omori R. An epidemiological analysis of the foot-and-mouth disease epidemic in Miyazaki, Japan 2010. Transboundary and Emerging Diseases 2010, 57:396-403.
173. Nugent C.I., Johnson K.L., Sarnow P., Kirkegaard K. Functional coupling between replication and packaging of poliovirus replicon RNA. Journal of Virology 1999, 73(1):427-435.
174. O'Donnell V., Larocco M., Baxt B. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. Journal of Virology 2008, 82(18):9075-9085.
175. O'Donnell V., LaRocco M., Duque H., Baxt B. Analysis of foot-and-mouth disease virus internalization events in cultured cells. Journal of Virology 2005, 79(13):8506-8518.
176. O'Donnell V., Pacheco J.M., Gregg D., Baxt B. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naive and infected cattle. Journal of Comparative Pathology 2009, 141(2-3):98-112.
177. O'Donnell V.K., Pacheco J.M., Henry T.M., Mason P.W. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology 2001, 287(1):151-162.
178. O'Donnell V., Pacheco J.M., LaRocco M., et al. Foot-and-mouth disease virus utilizes an autophagic pathway during viral replication. Virology 2011, 410(1):142-150.
179. van Ooij M., Polacek C., Glaudemans D., et al. Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element. Nucleic Acids Research 2006, 34:2953-2965.
180. Ostrowski M., Vermeulen M., Zabal O., et al. Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. Journal of Immunology 2005, 175:3971-3979.
181. Pacheco A., Lopez de Quinto S., Ramajo J., Fernandez N., Martinez-Salas E. A novel role for Gemin5 in mRNA translation. Nucleic Acids Research 2009, 37(2):582-590.
182. Pacheco A., Martinez-Salas E. Insights into the biology of IRES elements through riboproteomic approaches. Journal of Biomedicine and Biotechnology 2010, 2010:458927.
183. Pacheco J.M., Brum M.C., Moraes M.P., Golde W.T., Grubman M.J. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 2005, 337:205-206.
184. Pacheco J.M., Henry T.M., O'Donnell V.K., Gregory J.B., Mason P.W. Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. Journal of Virology 2003, 77(24):13017-13027.
185. Parida S. Vaccination against foot-and-mouth disease virus: Strategies and effectiveness. Expert Review of Vaccines 2009, 8:347-365.
186. Park J.H., Lee K.H., Ko Y.J., et al. Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease a type in the Republic of Korea. Transboundary and Emerging Diseases 2012, 60:188-192.
187. Pathak H.B., Oh H.S., Goodfellow I.G., Arnold J.J., Cameron C.E. Picornavirus genome replication: Roles of precursor proteins and rate-limiting steps in oril-dependent VPg uridylylation. Journal of Biological Chemistry 2008, 283:30677-30688.
188. Paul A.V., van Boom J.H., Filippov D., Wimmer E. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 1998, 393(6682):280-284.
189. Pega J., Bucafusco D., Di G., et al. Early adaptive immune response in the respiratory tract of foot-and-mouth disease virus-infected cattle. Journal of Virology 2013, 87:2489-2495.
190. Pena L., Moraes M.P., Koster M., et al. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 2008, 26:5689-5699.
191. Perez-Martin E., Weiss M., Diaz-San Segundo F., et al. Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. Journal of Virology 2012, 86(8):4477-4487.
192. Piccone M.E., Pacheco J.M., Pauszek S.J., et al. The region between the two polyprotein initiation codons of foot-and-mouth disease virus is critical for virulence in cattle. Virology 2010, 396(1):152-159.
193. Piccone M.E., Pauszek S., Pacheco J., et al. Molecular characterization of a foot-and-mouth disease virus containing a 57-nucleotide insertion in the 3' unstranslated region. Archives of Virology 2009, 154:671-676.
194. Piccone M.E., Rieder E., Mason P.W., Grubman M.J. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. Journal of Virology 1995, 69(9):5376-5382.
195. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309(5963):30-33.
196. Pierschbacher M.D., Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proceedings of the National Academy of Sciences USA 1984, 81(19):5985-5988.
197. Pilipenko E.V., Maslova S.V., Sinyakov A.N., Agol V.I. Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: A proposal for the existence of tRNA-like terminal structures. Nucleic Acids Research 1992, 20(7):1739-1745.
198. Pilipenko E.V., Pestova T.V., Kolupaeva V.G., et al. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes and Development 2000, 14(16):2028-2045.
199. Pilipenko E.V., Poperechny K.V., Maslova S.V., et al. Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: A quasi-globular multi-domain RNA structure maintained by tertiary ('kissing') interactions. EMBO Journal 1996, 15(19):5428-5436.
200. Pineiro D., Ramajo J., Bradrick S.S., Martinez-Salas E. Gemin5 proteolysis reveals a novel motif to identify L protease targets. Nucleic Acids Research 2012, 40(11):4942-4953.
201. Pluimers F.H., Akkerman A.M., van der Wal P., Dekker A., Bianchi A. Lessons from the foot and mouth disease outbreak in the Netherlands in 2001. Revue Scientifique et Technique (International Office of Epizootics) 2002, 21:711-721.
202. Porta C., Xu X., Loureiro S., et al. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. Journal of Virological Methods 2013, 187:406-412.
203. Rai D.K., Schafer E.A., Singh K., et al. Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells. Antiviral Research 2013, 98(3):380-385.
204. Ray D.K., Bhattacharyya U.K., Chowdhury B., Dasgupta P., Bhattacharyya A.K. Studies on a severe outbreak of foot-and-mouth disease in regularly vaccinated cross-exotic dairy cattle in West Bengal (India). Indian Journal of Animal Health 1989, 28:50-55.
205. Reid E., Juleff N., Gubbins S., et al. Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. Journal of Virology 2011, 85(9):4297-4308.
206. Ridgen R.C., Carrasco C.P., Summerfield A., McCullough K.C. Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology 2002, 106:537-548.
207. Robinson L., Windsor M., McLaughlin K., et al. Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. Journal of Virology 2011, 85(5):2212-2223.
208. Rodriguez L., Grubman M.J. Foot-and-mouth disease virus vaccines. Vaccine 2009, 27:90-94.
209. Rodriguez-Calvo T., Diaz-San Segundo F., Sanz-Ramos M., Sevilla N. A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier state in pigs. Veterinary Research 2011, 42:22.
210. Rodriguez-Pulido M., Serrano P., Saiz M., Martinez-Salas E. Foot-and-mouth disease virus infection induces proteolytic cleavage of PTB, eIF3a,b, and PABP RNA-binding proteins. Virology 2007, 364:466-474.
211. Rosas M.F., Martinez-Salas E., Sobrino F. Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. Journal of General Virology 2003, 84(Pt 2):393-402.
212. Rowlands D.J., Sangar D.V., Brown F. A comparative chemical and serological study of the full and empty particles of foot-and-mouth disease virus. Journal of General Virology 1974, 26:227-238.
213. Rozovics J.M., Semler B.L. Genomic replication I and II. The Picornaviruses 2010, 107-140. ASM Press, Washington, DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
214. Rozovics J.M., Virgen-Slane R., Semler B.L. Engineered picornavirus VPg-RNA substrates: Analysis of a tyrosyl-RNA phosphodiesterase activity. PLoS One 2011, 6(3):e16559.
215. Rweyemamu M.M., Terry G., Pay T.W. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Archives of Virology 1979, 59(1-2):69-79.
216. Ryan M.D., King A.M., Thomas G.P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. Journal of General Virology 1991, 72(Pt 11):2727-2732.
217. Sa-Carvalho D., Rieder E., Baxt B., et al. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. Journal of Virology 1997, 71(7):5115-5123.
218. Sagedahl A., Giraudo A.T., De Mello P.A., et al. Biochemical characterization of an aphthovirus type C3 strain Resende attenuated for cattle by serial passages in chicken embryos. Virology 1987, 157:366-374.
219. Saiz M., Gomez S., Martinez-Salas E., Sobrino F. Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. Journal of General Virology 2001, 82(Pt 1):93-101.
220. Sakamoto K., Yoshida K. Recent outbreaks of foot and mouth disease in countries of east Asia. Revue Scientifique et Technique (International Office of Epizootics) 2002, 21:459-463.
221. Salt J.S. The carrier state in foot and mouth disease - An immunological review. British Veterinary Journal 1993, 149(3):207-223.
222. Salt J.S., Mulcahy G., Kitching R.P. Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier" and "non-carrier" cattle. Epidemiology and Infection 1996, 117(2):349-360.
223. de los Santos T., de Avila Botton S., Weiblen R., Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. Journal of Virology 2006, 80(4):1906-1914.
224. de los Santos T., Diaz-San Segundo F., Grubman M.J. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. Journal of Virology 2007, 81(23):12803-12815.
225. de los Santos T., Wu Q., de Avila Botton S., Grubman M.J. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 2005, 335(2):222-231.
226. Sanz-Parra A., Sobrino F., Ley V. Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. Journal of General Virology 1998, 79(Pt 3):433-436.
227. Scudamore J.M., Harris D.M. Control of foot and mouth disease: Lessons from the experience of the outbreak in Great Britain in 2001. Revue Scientifique et Technique (International Office of Epizootics) 2002, 21:699-710.
228. Sorensen J.H., Mackay D.K., Jensen C.O., Donaldson A.I. An integrated model to predict the atmospheric spread of foot-and-mouth disease virus. Epidemiology and Infection 2000, 124(3):577-590.
229. Strebel K., Beck E. A second protease of foot-and-mouth disease virus. Journal of Virology 1986, 58(3):893-899.
230. Strohmaier K., Franze R., Adam K.H. Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 1982, 59(Pt 2):295-306.
231. Sumption, K., McLaws, M., Bartels, C., et al., 2012. The progressive control pathway for FMD (PCP-FMD): A tool for developing sustainable long term national and regional FMD control. FAO/OIE Global Conference on Foot and Mouth Disease Control.
232. Sutmoller P., Barteling S.S., Olascoaga R.C., Sumption K.J. Control and eradication of foot-and-mouth disease. Virus Research 2003, 91(1):101-144.
233. Sutmoller P., Casas O.R. Unapparent foot and mouth disease infection (sub-clinical infections and carriers): Implications for control. Revue Scientifique et Technique 2002, 21(3):519-529.
234. Sutmoller P., McVicar J.W., Cottral G.E. The epizootiological importance of foot-and-mouth disease carriers. I. Experimentally produced foot-and-mouth disease carriers in susceptible and immune cattle. Archiv für die gesamte Virusforschung 1968, 23:227-235.
235. Taboga O., Tami C., Carrillo E., et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 1997, 71(4):2606-2614.
236. Tesar M., Berger H.G., Marquardt O. Serological probes for some foot-and-mouth disease virus nonstructural proteins. Virus Genes 1989, 3(1):29-44.
237. Toka F.N., Nfon C., Dawson H., Golde W.T. Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. Clinical and Vaccine Immunology 2009, 16:1738-1749.
238. Uddowla S., Hollister J., Pacheco J.M., Rodriguez L.L., Rieder E. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. Journal of Virology 2012, 86(21):11675-11685.
239. Vagnozzi A., Stein D.A., Iversen P.L., Rieder E. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. Journal of Virology 2007, 81:11669-11680.
240. Vakharia V.N., Devaney M.A., Moore D.M., Dunn J.J., Grubman M.J. Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. Journal of Virology 1987, 61(10):3199-3207.
241. Vivier E., Raulet D.H., Moretta A., et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
242. Vosloo W., Bastos A.D., Kirkbride E., et al. Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: Rate of fixation of mutations, antigenic change and interspecies transmission. Journal of General Virology 1996, 77(Pt 7):1457-1467.
243. Wang D., Fang L., Bi J., et al. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells. Virus Genes 2011, 42(3):388-393.
244. Wang D., Fang L., Li K., et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. Journal of Virology 2012, 86(17):9311-9322.
245. Wang D., Fang L., Li P., et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. Journal of Virology 2011, 85(8):3758-3766.
246. Wilson V., Taylor P., Desselberger U. Crossover regions in foot-and-mouth disease virus (FMDV) recombinants correspond to regions of high local secondary structure. Archives of Virology 1988, 102(1-2):131-139.
247. Windsor M.A., Carr B.V., Bankowski B., et al. Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. Veterinary Research 2011, 42(1):108.
248. Woodbury E.L. A review of the possible mechanisms for the persistence of foot-and-mouth disease virus. Epidemiology and Infection 1995, 114(1):1-13.
249. Wu Q., Brum M.C.S., Caron L., Koster M., Grubman M.J. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. Journal of Interferon and Cytokine Research 2003, 23(7):359-368.
250. Yang P.C., Chu R.M., Chung W.B., Sung H.T. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Veterinary Record 1999, 145(25):731-734.
251. Yoon H., Yoon S.S., Wee S.H., Kim Y.J., Kim B. Clinical manifestations of foot-and-mouth disease during the 2010/2011 epidemic in the Republic of Korea. Transboundary and Emerging Diseases 2012, 59:517-525.
252. Zhang J., Tarbet E.B., Toro H., Tang D.C. Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases. Expert Review of Vaccines 2011, 10:1539-1552.
253. Zhang Z., Ahmed R., Paton D., Bashiruddin J.B. Cytokine mRNA responses in bovine epithelia during foot-and-mouth disease virus infection. Veterinary Jounral 2009, 179(1):85-91.
254. Zhang Z., Kitching R.P. The localization of persistent foot and mouth disease virus in the epithelial cells of the soft palate and pharynx. Journal of Comparative Pathology 2001, 124(2-3):89-94.
255. Zhang Z.D., Hutching G., Kitching P., Alexandersen S. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Archives of Virology 2002, 147(11):2157-2167.
256. Zhao Q., Pacheco J.M., Mason P.W. Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals. Journal of Virology 2003, 77(5):3269-3280.
257. Zhu J., Weiss M., Grubman M.J., de los Santos T. Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus. Virology 2010, 404(1):32-40.
258. Ziegler E., Borman A.M., Kirchweger R., Skern T., Kean K.M. Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin. Journal of Virology 1995, 69(6):3465-3474.